$4.310
+0.041 (+0.94%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AVIR Prediction & Forecast by Similar Chart Analysis
Alphio's AVIR stock price prediction model matches the current Atea Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.16 (+1.13%). The 1-week path is $4.18 (+1.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Atea Pharmaceuticals, Inc. Stock?
Atea Pharmaceuticals Inc is currently not a strong buy due to its low RSI of 15.657, indicating it is oversold, and a current price of $4.04, which is below the Fibonacci Pivot level of $4.527. However, the stock has shown a year-to-date change of +16.09% and a one-year change of +24.31%, suggesting potential for recovery. The main risk is the negative earnings trend, with an EPS of -0.41 reported in the last quarter, which could affect future performance.
AVIR stock price ended at $4.31 on Thursday, after rising +0.94%
Atea Pharmaceuticals, Inc. (AVIR) last closed at $4.1100001, losing -4.64%. These facts feed the 1-day and 1-week AVIR price prediction above.
Forecast Drivers
Atea Pharmaceuticals, Inc. (AVIR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AVIR, ranked by similarity.
Seasonality analysis for AVIR
Historically the probability of a positive October return for AVIR is 66.18%. August offers the highest probability of a positive month at 96.88%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AVIR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $3.37 | $3.37 | $3.62 | -17.96% |
| Nov 2026 | $3.95 | $4.06 | $4.59 | -1.28% |
| Dec 2026 | $3.53 | $3.58 | $4.03 | -12.95% |
In 2026, Atea Pharmaceuticals, Inc. (AVIR) is projected to range from $3.37 to $4.59.
Atea Pharmaceuticals, Inc. 2026 monthly forecast
In Oct 2026, Atea Pharmaceuticals, Inc. is projected to average $3.37, with a low of $3.37 and high of $3.62.
In Nov 2026, Atea Pharmaceuticals, Inc. is projected to average $4.06, with a low of $3.95 and high of $4.59.
In Dec 2026, Atea Pharmaceuticals, Inc. is projected to average $3.58, with a low of $3.53 and high of $4.03.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.